MCL-1 expression in B-cell non-Hodgkin's lymphomas

Jeong Hee Cho, George Z. Rassidakis, Joan H. Admirand, Mauricio Oyarzo, Preetha Ramalingam, Aris Paraguya, Timothy J. McDonnell, Hesham M. Amin, L. Jeffrey Medeiros

Research output: Contribution to journalArticle

73 Citations (Scopus)

Abstract

B-cell non-Hodgkin's lymphomas are known to express BCL-2 family proteins, of which the myeloid cell leukemia-1 (MCL-1) protein is a member. MCL-1 is involved in viability and immortalization of normal and neoplastic B cells, and expression is regulated transcriptionally and posttranscriptionally, resulting in an anti-apoptotic (full length) or a pro-apoptotic (short isoform) gene product. In this study, we assessed 151 B-cell lymphomas for MCL-1 expression and analyzed for expression of the full-length and short isoforms of MCL-1 in B-cell lymphoma cell lines. By using immunohistochemistry, a subset of neoplasms in 9 lymphoma types studied expressed MCL-1, but expression was more frequent and intense in high-grade (43 of 49, 88%) compared with low-grade (34 of 92, 37%) lymphomas (P < 0.0001). In follicular lymphomas, MCL-1 expression positively correlated with increasing grade; 1 (14%) of eight grade 1, 7 (70%) of ten grade 2, and all 9 (100%) grade 3 were positive (P < 0.0008). All plasma cell myeloma cases assessed were also MCL-1 positive. By using Western blot analysis, 6 of 7 high-grade B-cell lymphoma cell lines showed predominant expression of full-length MCL-1, compared with no or weak expression of the short isoform. One myeloma and 1 of 2 mantle cell lymphoma cell lines also tested showed only full-length isoform expression. Our data suggest that MCL-1 is frequently expressed in high-grade B-cell lymphomas and plasma cell myeloma, most likely in its full-length isoform that is an active anti-apoptotic gene product. MCL-1 expression also correlates with grade and may contribute to transformation in follicular lymphomas.

Original languageEnglish (US)
Pages (from-to)1095-1100
Number of pages6
JournalHuman Pathology
Volume35
Issue number9
DOIs
StatePublished - Sep 2004
Externally publishedYes

Fingerprint

Myeloid Leukemia
B-Cell Lymphoma
Myeloid Cells
Non-Hodgkin's Lymphoma
Protein Isoforms
Follicular Lymphoma
Multiple Myeloma
Cell Line
Lymphoma
Mantle-Cell Lymphoma
Genes
Proteins
B-Lymphocytes
Western Blotting
Immunohistochemistry

Keywords

  • B-cell
  • BCL-2 homology 3
  • BH3
  • immunohistochemistry
  • MALT
  • MCL-1
  • MCL-1 protein
  • mucosa-associated lymphoma tissue
  • myeloid cell leukemia-1 protein
  • non-Hodgkin's lymphoma

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Cho, J. H., Rassidakis, G. Z., Admirand, J. H., Oyarzo, M., Ramalingam, P., Paraguya, A., ... Medeiros, L. J. (2004). MCL-1 expression in B-cell non-Hodgkin's lymphomas. Human Pathology, 35(9), 1095-1100. https://doi.org/10.1016/j.humpath.2004.04.018

MCL-1 expression in B-cell non-Hodgkin's lymphomas. / Cho, Jeong Hee; Rassidakis, George Z.; Admirand, Joan H.; Oyarzo, Mauricio; Ramalingam, Preetha; Paraguya, Aris; McDonnell, Timothy J.; Amin, Hesham M.; Medeiros, L. Jeffrey.

In: Human Pathology, Vol. 35, No. 9, 09.2004, p. 1095-1100.

Research output: Contribution to journalArticle

Cho, JH, Rassidakis, GZ, Admirand, JH, Oyarzo, M, Ramalingam, P, Paraguya, A, McDonnell, TJ, Amin, HM & Medeiros, LJ 2004, 'MCL-1 expression in B-cell non-Hodgkin's lymphomas', Human Pathology, vol. 35, no. 9, pp. 1095-1100. https://doi.org/10.1016/j.humpath.2004.04.018
Cho JH, Rassidakis GZ, Admirand JH, Oyarzo M, Ramalingam P, Paraguya A et al. MCL-1 expression in B-cell non-Hodgkin's lymphomas. Human Pathology. 2004 Sep;35(9):1095-1100. https://doi.org/10.1016/j.humpath.2004.04.018
Cho, Jeong Hee ; Rassidakis, George Z. ; Admirand, Joan H. ; Oyarzo, Mauricio ; Ramalingam, Preetha ; Paraguya, Aris ; McDonnell, Timothy J. ; Amin, Hesham M. ; Medeiros, L. Jeffrey. / MCL-1 expression in B-cell non-Hodgkin's lymphomas. In: Human Pathology. 2004 ; Vol. 35, No. 9. pp. 1095-1100.
@article{e19f21d2c7b443388856a4423ceb629f,
title = "MCL-1 expression in B-cell non-Hodgkin's lymphomas",
abstract = "B-cell non-Hodgkin's lymphomas are known to express BCL-2 family proteins, of which the myeloid cell leukemia-1 (MCL-1) protein is a member. MCL-1 is involved in viability and immortalization of normal and neoplastic B cells, and expression is regulated transcriptionally and posttranscriptionally, resulting in an anti-apoptotic (full length) or a pro-apoptotic (short isoform) gene product. In this study, we assessed 151 B-cell lymphomas for MCL-1 expression and analyzed for expression of the full-length and short isoforms of MCL-1 in B-cell lymphoma cell lines. By using immunohistochemistry, a subset of neoplasms in 9 lymphoma types studied expressed MCL-1, but expression was more frequent and intense in high-grade (43 of 49, 88{\%}) compared with low-grade (34 of 92, 37{\%}) lymphomas (P < 0.0001). In follicular lymphomas, MCL-1 expression positively correlated with increasing grade; 1 (14{\%}) of eight grade 1, 7 (70{\%}) of ten grade 2, and all 9 (100{\%}) grade 3 were positive (P < 0.0008). All plasma cell myeloma cases assessed were also MCL-1 positive. By using Western blot analysis, 6 of 7 high-grade B-cell lymphoma cell lines showed predominant expression of full-length MCL-1, compared with no or weak expression of the short isoform. One myeloma and 1 of 2 mantle cell lymphoma cell lines also tested showed only full-length isoform expression. Our data suggest that MCL-1 is frequently expressed in high-grade B-cell lymphomas and plasma cell myeloma, most likely in its full-length isoform that is an active anti-apoptotic gene product. MCL-1 expression also correlates with grade and may contribute to transformation in follicular lymphomas.",
keywords = "B-cell, BCL-2 homology 3, BH3, immunohistochemistry, MALT, MCL-1, MCL-1 protein, mucosa-associated lymphoma tissue, myeloid cell leukemia-1 protein, non-Hodgkin's lymphoma",
author = "Cho, {Jeong Hee} and Rassidakis, {George Z.} and Admirand, {Joan H.} and Mauricio Oyarzo and Preetha Ramalingam and Aris Paraguya and McDonnell, {Timothy J.} and Amin, {Hesham M.} and Medeiros, {L. Jeffrey}",
year = "2004",
month = "9",
doi = "10.1016/j.humpath.2004.04.018",
language = "English (US)",
volume = "35",
pages = "1095--1100",
journal = "Human Pathology",
issn = "0046-8177",
publisher = "W.B. Saunders Ltd",
number = "9",

}

TY - JOUR

T1 - MCL-1 expression in B-cell non-Hodgkin's lymphomas

AU - Cho, Jeong Hee

AU - Rassidakis, George Z.

AU - Admirand, Joan H.

AU - Oyarzo, Mauricio

AU - Ramalingam, Preetha

AU - Paraguya, Aris

AU - McDonnell, Timothy J.

AU - Amin, Hesham M.

AU - Medeiros, L. Jeffrey

PY - 2004/9

Y1 - 2004/9

N2 - B-cell non-Hodgkin's lymphomas are known to express BCL-2 family proteins, of which the myeloid cell leukemia-1 (MCL-1) protein is a member. MCL-1 is involved in viability and immortalization of normal and neoplastic B cells, and expression is regulated transcriptionally and posttranscriptionally, resulting in an anti-apoptotic (full length) or a pro-apoptotic (short isoform) gene product. In this study, we assessed 151 B-cell lymphomas for MCL-1 expression and analyzed for expression of the full-length and short isoforms of MCL-1 in B-cell lymphoma cell lines. By using immunohistochemistry, a subset of neoplasms in 9 lymphoma types studied expressed MCL-1, but expression was more frequent and intense in high-grade (43 of 49, 88%) compared with low-grade (34 of 92, 37%) lymphomas (P < 0.0001). In follicular lymphomas, MCL-1 expression positively correlated with increasing grade; 1 (14%) of eight grade 1, 7 (70%) of ten grade 2, and all 9 (100%) grade 3 were positive (P < 0.0008). All plasma cell myeloma cases assessed were also MCL-1 positive. By using Western blot analysis, 6 of 7 high-grade B-cell lymphoma cell lines showed predominant expression of full-length MCL-1, compared with no or weak expression of the short isoform. One myeloma and 1 of 2 mantle cell lymphoma cell lines also tested showed only full-length isoform expression. Our data suggest that MCL-1 is frequently expressed in high-grade B-cell lymphomas and plasma cell myeloma, most likely in its full-length isoform that is an active anti-apoptotic gene product. MCL-1 expression also correlates with grade and may contribute to transformation in follicular lymphomas.

AB - B-cell non-Hodgkin's lymphomas are known to express BCL-2 family proteins, of which the myeloid cell leukemia-1 (MCL-1) protein is a member. MCL-1 is involved in viability and immortalization of normal and neoplastic B cells, and expression is regulated transcriptionally and posttranscriptionally, resulting in an anti-apoptotic (full length) or a pro-apoptotic (short isoform) gene product. In this study, we assessed 151 B-cell lymphomas for MCL-1 expression and analyzed for expression of the full-length and short isoforms of MCL-1 in B-cell lymphoma cell lines. By using immunohistochemistry, a subset of neoplasms in 9 lymphoma types studied expressed MCL-1, but expression was more frequent and intense in high-grade (43 of 49, 88%) compared with low-grade (34 of 92, 37%) lymphomas (P < 0.0001). In follicular lymphomas, MCL-1 expression positively correlated with increasing grade; 1 (14%) of eight grade 1, 7 (70%) of ten grade 2, and all 9 (100%) grade 3 were positive (P < 0.0008). All plasma cell myeloma cases assessed were also MCL-1 positive. By using Western blot analysis, 6 of 7 high-grade B-cell lymphoma cell lines showed predominant expression of full-length MCL-1, compared with no or weak expression of the short isoform. One myeloma and 1 of 2 mantle cell lymphoma cell lines also tested showed only full-length isoform expression. Our data suggest that MCL-1 is frequently expressed in high-grade B-cell lymphomas and plasma cell myeloma, most likely in its full-length isoform that is an active anti-apoptotic gene product. MCL-1 expression also correlates with grade and may contribute to transformation in follicular lymphomas.

KW - B-cell

KW - BCL-2 homology 3

KW - BH3

KW - immunohistochemistry

KW - MALT

KW - MCL-1

KW - MCL-1 protein

KW - mucosa-associated lymphoma tissue

KW - myeloid cell leukemia-1 protein

KW - non-Hodgkin's lymphoma

UR - http://www.scopus.com/inward/record.url?scp=4444365042&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4444365042&partnerID=8YFLogxK

U2 - 10.1016/j.humpath.2004.04.018

DO - 10.1016/j.humpath.2004.04.018

M3 - Article

VL - 35

SP - 1095

EP - 1100

JO - Human Pathology

JF - Human Pathology

SN - 0046-8177

IS - 9

ER -